Healthcare provider profile · identity verified

David L Danielson, MD

Family Practice · REDWOOD FALLS, MN · NPI 1679885974

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	513	103
Amlodipine Besylate	Amlodipine Besylate	429	95
Losartan Potassium	Losartan Potassium	422	90
Metoprolol Succinate	Metoprolol Succinate	389	73
Lisinopril	Lisinopril	375	76
Omeprazole	Omeprazole	334	71
Levothyroxine Sodium	Levothyroxine Sodium	312	58
Rosuvastatin Calcium	Rosuvastatin Calcium	247	52
Gabapentin	Gabapentin	213	52
Furosemide	Furosemide	207	44
Warfarin Sodium	Warfarin Sodium	173	25
Torsemide	Torsemide	166	33
Eliquis	Apixaban	157	23
Carvedilol	Carvedilol	156	27
Fluticasone Propionate	Fluticasone Propionate	154	55
Sertraline Hcl	Sertraline Hcl	152	38
Tamsulosin Hcl	Tamsulosin Hcl	152	36
Potassium Chloride	Potassium Chloride	143	35
Pantoprazole Sodium	Pantoprazole Sodium	134	32
Metformin Hcl	Metformin Hcl	129	24
Jantoven	Warfarin Sodium	122	14
Allopurinol	Allopurinol	120	23
Chlorthalidone	Chlorthalidone	111	23
Alendronate Sodium	Alendronate Sodium	108	19
Ozempic	Semaglutide	106	19
Famotidine	Famotidine	105	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	36
Spironolactone	Spironolactone	102	18
Trazodone Hcl	Trazodone Hcl	98	23
Simvastatin	Simvastatin	95	18
Bupropion Xl	Bupropion Hcl	93	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	15
Finasteride	Finasteride	84	15
Clopidogrel	Clopidogrel Bisulfate	79	16
Pravastatin Sodium	Pravastatin Sodium	75	22
Atenolol	Atenolol	71	13
Jardiance	Empagliflozin	71	16
Duloxetine Hcl	Duloxetine Hcl	62	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	61	18
Donepezil Hcl	Donepezil Hcl	58	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	55	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	54	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	51	12
Metformin Hcl Er	Metformin Hcl	48	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	47	suppressed
Pregabalin	Pregabalin	43	suppressed
Tramadol Hcl	Tramadol Hcl	41	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	40	22
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	22
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Meloxicam	Meloxicam	36	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Irbesartan	Irbesartan	35	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	28	suppressed
Humalog Kwikpen U-100	Insulin Lispro	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Carbamazepine	Carbamazepine	26	suppressed
Dilantin	Phenytoin Sodium Extended	26	suppressed
Repatha Syringe	Evolocumab	26	suppressed
Spiriva Handihaler	Tiotropium Bromide	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Constulose	Lactulose	25	suppressed
Creon	Lipase/Protease/Amylase	25	suppressed
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Labetalol Hcl	Labetalol Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	11
Oxycodone Hcl	Oxycodone Hcl	23	12
Prednisone	Prednisone	23	17
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Arnuity Ellipta	Fluticasone Furoate	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	22	suppressed
Clonidine	Clonidine	21	suppressed
Linzess	Linaclotide	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Nystatin	Nystatin	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Cefdinir	Cefdinir	17	15
Cephalexin	Cephalexin	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Risperidone	Risperidone	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Naproxen	Naproxen	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Cartia Xt	Diltiazem Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Victoza 3-Pak	Liraglutide	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error